Kazia Therapeutics Ltd (ASX:KZA) insider James Garner bought 65,000 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was bought at an average cost of A$0.33 ($0.23) per share, with a total value of A$21,515.00 ($15,258.87).
KZA stock opened at A$0.64 ($0.45) on Thursday. The firm has a 50-day moving average price of A$0.51 and a 200-day moving average price of A$0.44. Kazia Therapeutics Ltd has a 12 month low of A$0.32 ($0.23) and a 12 month high of A$0.80 ($0.57). The stock has a market capitalization of $39.79 million and a P/E ratio of -3.58.
About Kazia Therapeutics
Further Reading: What is a Real Estate Investment Trust (REIT)?
Receive News & Ratings for Kazia Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kazia Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.